Back to search

Netherlands· NL-c3a7770f5d97

Porontazin 1 microgram, zachte capsules

A paricalcitol product containing paricalcitol, registered in Netherlands by Regiomedica GmbH. The same ATC class is registered in 12 of our 19 countries.

ATC H05BX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPorontazin 1 microgram, zachte capsul…ATCH05BX02REGISTER NO.NL-c3a7770f5d97PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Paricalcitol is registered in 12 of 19 countries.

Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Paricalcitol · ATC H05BX02

12 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paricalcitol costs, country by country.

Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paricalcitol · price per daily dose (2 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PARICALCITOL
Manufacturer
Regiomedica GmbH
Country
Netherlands (NL)
ATC code
H05BX02
ATC class
Paricalcitol
Defined daily dose
2 mcg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    113731

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

285 interactions on record for paricalcitol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paricalcitol · interactions on record

285 records

  • 11 severe
  • 108 moderate
  • 166 info

Most severe, free to view

  • SucralfateA02BX02severe
  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paricalcitol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paricalcitol products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Paricalcitol Accord, Zemplar
  • Bulgaria · Тевапаривит
  • Cyprus · Rextol
  • Czechia · Paricalcitol Accord, Paricalcitol Agmed
  • Germany · Paricalcitol Accord, Paricalcitol Hexal
  • Denmark · Paricalcitol Pharmathen
  • Spain · Paricalcitol Accord, Paricalcitol Accordpharma
  • Finland · Paricalcitol Accord, Paricalcitol Alternova
  • United Kingdom (Northern Ireland) · Zemplar
  • Greece · Aricitol, Panozin
  • Croatia · Parkol, Zemplar
  • Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
  • Ireland · Paricalcitol Pinewood Laboratories, Zemplar
  • Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
  • Luxembourg · Porontazin
  • Norway · Paricalcitol Alternova
  • Poland · Paricalcitol Fresenius
  • Portugal · Paricalcitol Accord, Paricalcitol Altan
  • Romania · Paricalcitol, Rextol
  • Sweden · Paricalcitol Accord, Paricalcitol Alternova
  • Slovenia · Zemplar
  • Slovakia · Paricalcitol Heaton, Zemplar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8756095f-0c29-4a13-89c3-b995806ed8ba
GET /v1/drugs/8756095f-0c29-4a13-89c3-b995806ed8ba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113731_smpc_en.pdf",
  "strength": null,
  "atc_label": "Paricalcitol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113731",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "ETHANOL 96 %",
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "TITAANDIOXIDE (E 171)",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "PARICALCITOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113731_piluk.pdf",
  "authorised_at": "2014/04/10",
  "procedure_number": "NL/H/2946/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "113731",
  "additional_monitoring": "N"
}

See everything about paricalcitol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.